Related Experiment Video
Updated: Jul 10, 2026
05:25
Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Inflammatory response in on- versus off-pump myocardial revascularization: is ECC really the culprit?
J Börgermann1, R J Scheubel, A Simm
1Department of Cardiac and Thoracic Surgery, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany. jochen.boergermann@t-online.de
The Thoracic and Cardiovascular Surgeon
|November 21, 2007
Summary
Systemic inflammation differs quantitatively, not qualitatively, between on-pump and off-pump surgery. More research is needed to confirm off-pump surgery
Area of Science:
- Cardiovascular Surgery
- Inflammatory Response
- Surgical Techniques
Background:
- Systemic inflammation is a known response to surgical trauma and ischemia/reperfusion.
- Genetic factors can modulate inflammatory responses during surgery.
- On-pump versus off-pump surgery presents different inflammatory profiles.
Purpose of the Study:
- To review and compare inflammatory mediators in on-pump versus off-pump cardiac surgery.
- To evaluate the quantitative and qualitative differences in systemic inflammation between surgical approaches.
- To assess the clinical significance of inflammatory responses in different surgical contexts.
Main Methods:
- Literature review of studies comparing inflammatory mediators in on-pump and off-pump surgery.
- Analysis of systemic inflammation parameters and cellular activation markers.
- Consideration of genetic modulation of inflammatory responses.
Main Results:
- Systemic inflammation parameters differ quantitatively, not qualitatively, between on-pump and off-pump surgery.
- Both surgical approaches trigger mediator system and cellular activation.
- Current literature lacks definitive evidence for off-pump surgery's superiority regarding systemic inflammation.
Conclusions:
- The systemic inflammatory response to on-pump and off-pump surgery is quantitatively distinct.
- Further large-scale studies are required to validate the clinical benefits of off-pump surgery over on-pump surgery concerning inflammatory response.
Related Concept Videos
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:30Inflammatory Response I: Vascular and Cellular
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...